A detailed history of Park National Corp transactions in Danaher Corp stock. As of the latest transaction made, Park National Corp holds 84,820 shares of DHR stock, worth $20 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
84,820
Previous 89,035 4.73%
Holding current value
$20 Million
Previous $22.2 Million 6.0%
% of portfolio
0.83%
Previous 0.83%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$239.25 - $280.76 $1.01 Million - $1.18 Million
-4,215 Reduced 4.73%
84,820 $23.6 Million
Q2 2024

Jul 15, 2024

SELL
$235.51 - $267.98 $90,671 - $103,172
-385 Reduced 0.43%
89,035 $22.2 Million
Q1 2024

Apr 01, 2024

SELL
$224.58 - $256.19 $1.98 Million - $2.26 Million
-8,809 Reduced 8.97%
89,420 $22.3 Million
Q4 2023

Jan 02, 2024

BUY
$185.1 - $233.13 $556,410 - $700,788
3,006 Added 3.16%
98,229 $22.7 Million
Q3 2023

Oct 02, 2023

SELL
$233.08 - $265.59 $696,909 - $794,114
-2,990 Reduced 3.04%
95,223 $23.6 Million
Q2 2023

Jul 03, 2023

SELL
$224.99 - $256.14 $488,678 - $556,336
-2,172 Reduced 2.16%
98,213 $23.6 Million
Q1 2023

Apr 03, 2023

SELL
$239.75 - $277.0 $1.04 Million - $1.2 Million
-4,346 Reduced 4.15%
100,385 $25.3 Million
Q4 2022

Feb 06, 2023

SELL
$241.42 - $282.29 $493,945 - $577,565
-2,046 Reduced 1.92%
104,731 $27.8 Million
Q3 2022

Oct 03, 2022

SELL
$247.06 - $1507.4 $1,235 - $7,537
-5 Reduced -0.0%
106,777 $27.6 Million
Q2 2022

Jul 01, 2022

BUY
$237.11 - $299.66 $738,834 - $933,740
3,116 Added 3.01%
106,782 $27.1 Million
Q1 2022

Apr 01, 2022

SELL
$257.27 - $315.76 $341,911 - $419,645
-1,329 Reduced 1.27%
103,666 $30.4 Million
Q4 2021

Jan 04, 2022

SELL
$292.08 - $329.01 $1.42 Million - $1.6 Million
-4,851 Reduced 4.42%
104,995 $34.5 Million
Q3 2021

Oct 01, 2021

SELL
$272.21 - $332.43 $2.28 Million - $2.78 Million
-8,358 Reduced 7.07%
109,846 $33.4 Million
Q2 2021

Jul 01, 2021

SELL
$225.08 - $271.69 $856,654 - $1.03 Million
-3,806 Reduced 3.12%
118,204 $31.7 Million
Q1 2021

Apr 01, 2021

SELL
$212.38 - $245.9 $1.5 Million - $1.74 Million
-7,059 Reduced 5.47%
122,010 $27.5 Million
Q4 2020

Jan 04, 2021

SELL
$212.5 - $245.46 $1.17 Million - $1.35 Million
-5,489 Reduced 4.08%
129,069 $28.7 Million
Q3 2020

Oct 01, 2020

SELL
$177.16 - $215.33 $1.29 Million - $1.57 Million
-7,281 Reduced 5.13%
134,558 $29 Million
Q2 2020

Jul 01, 2020

SELL
$128.7 - $176.83 $594,207 - $816,424
-4,617 Reduced 3.15%
141,839 $25.1 Million
Q1 2020

Apr 01, 2020

SELL
$121.39 - $169.05 $795,711 - $1.11 Million
-6,555 Reduced 4.28%
146,456 $20.3 Million
Q4 2019

Jan 02, 2020

BUY
$133.47 - $153.48 $366,108 - $420,995
2,743 Added 1.83%
153,011 $23.5 Million
Q3 2019

Oct 01, 2019

BUY
$135.4 - $146.47 $834,199 - $902,401
6,161 Added 4.28%
150,268 $21.7 Million
Q2 2019

Jul 01, 2019

SELL
$124.88 - $143.73 $671,105 - $772,405
-5,374 Reduced 3.6%
144,107 $20.6 Million
Q1 2019

Apr 01, 2019

BUY
$97.62 - $132.29 $150,139 - $203,462
1,538 Added 1.04%
149,481 $19.7 Million
Q4 2018

Jan 02, 2019

BUY
$94.85 - $109.54 $740,019 - $854,631
7,802 Added 5.57%
147,943 $15.3 Million
Q3 2018

Oct 02, 2018

BUY
$98.13 - $108.9 $782,783 - $868,695
7,977 Added 6.04%
140,141 $15.2 Million
Q2 2018

Jul 02, 2018

BUY
$96.1 - $103.24 $916,313 - $984,393
9,535 Added 7.78%
132,164 $13 Million
Q1 2018

Apr 02, 2018

BUY
$92.16 - $103.8 $261,918 - $294,999
2,842 Added 2.37%
122,629 $12 Million
Q4 2017

Jan 02, 2018

BUY
$85.26 - $94.62 $632,629 - $702,080
7,420 Added 6.6%
119,787 $11.1 Million
Q3 2017

Oct 02, 2017

BUY
$79.29 - $88.45 $8.91 Million - $9.94 Million
112,367
112,367 $9.64 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Park National Corp Portfolio

Follow Park National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.